on 29 Mar 2022
Last Applicant/ Owned by
ImmunoVaccine Technologies Inc.
130 Eileen Stubbs Avenue, Suite 19
Dartmouth, Nova Scotia, , B3B 2C4
Serial Number
UK00003771343 filed on 29th Mar 2022
Correspondent Information
Potter Clarkson LLP
The Belgrave Centre, Talbot Street
Nottingham,
NG1 5GG
Drug delivery technology in the form of lipid vesicles, that can be formulated with a wide variety of bioactive molecules and results in a specific immune response.
Pharmaceutical research and development; laboratory research in the fields of chemistry and biochemistry; research in the field of pharmaceutical drug delivery; medical research; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; hosting websites with information in the field of pharmaceutical research and development.
UK00003771343
Word
Individual